Analyst consensus rating
Biomea Fusion Analyst Rating: Buy
Direct answer
Biomea Fusion's consensus rating is Buy.
6 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $6.17.
Forecast evidence checked October 18, 2026.
Get free Biomea Fusion email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $0.87
- Average price target
- $6.17
- High price target
- $10.00
- Low price target
- $4.00
- Low target gap
- +360.4%
- Target upside
- +609.7%
- High target gap
- +1,050.9%
- Target range width
- 690.5%
- Consensus rating
- Buy
- Analysts
- 6
- Evidence date
- October 18, 2026
- Valid through
- October 25, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Biomea Fusion?
Biomea Fusion has a verified Buy consensus. The same dataset has an average price target of $6.17.
How far are Biomea Fusion's low and high targets from the recorded price?
The low target implies +360.4%, while the high target implies +1,050.9%.
How many analysts are included in Biomea Fusion's consensus?
The verified consensus includes 6 analysts.
How is Biomea Fusion's target upside or downside calculated?
The average target of $6.17 is divided by the recorded price of $0.87, then one is subtracted to produce +609.7%. This does not guarantee a future return.
When was Biomea Fusion's analyst forecast verified?
The data was verified on 2026-10-18. The dataset is valid through 2026-10-25.